Dose-response relationship for lung cancer induction at radiotherapy dose;Ableitung einer Dosis-Wirkungs-Beziehung für die Induktion von Lungenkrebs nach Strahlentherapiedosen

Zeitschrift fur Medizinische Physik

Volumn 20, Issue 3, 2010, Pages 206-214

  Schneider, Uwe ^a,b   Stipper, Andrea ^b   Besserer, Jürgen ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Radiotherapy Hirslanden AG   (Switzerland)

Author keywords

Carcinogenesis; Lung cancer; Second cancer

Indexed keywords

ARTICLE; CANCER MODEL; CANCER RADIOTHERAPY; CANCER RISK; HODGKIN DISEASE; HUMAN; LUNG CANCER; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; SECOND CANCER; STATISTICAL PARAMETERS; TISSUE INJURY; TISSUE REPAIR; TREATMENT PLANNING;

DOSE FRACTIONATION; HUMANS; LUNG; LUNG NEOPLASMS; PHANTOMS, IMAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RISK FACTORS;

EID: 77956619235     PISSN: 09393889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zemedi.2010.03.008     Document Type: Article

References (20)

1. Dörr W., Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol 2002, 178(7):357-362.
2. Travis L.B., Gospodarowicz M., Curtis R.E., Clarke E.A., Andersson M., Glimelius B., Joensuu T., Lynch C.F., van Leeuwen F.E., Holowaty E., Storm H., Glimelius I., Pukkala E., Stovall M., Fraumeni J.F., Boice J.D., Gilbert E. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst. 2002, 94(3):182-192.
3. Gilbert E.S., Stovall M., Gospodarowicz M., Van Leeuwen F.E., Andersson M., Glimelius B., Joensuu T., Lynch C.F., Curtis R.E., Holowaty E., Storm H., Pukkala E., van't Veer M.B., Fraumeni J.F., Boice J.D., Clarke E.A., Travis L.B. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res. 2003, 159(2):161-173.
4. Diallo I., Haddy N., Adjadj E., Samand A., Quiniou E., Chavaudra J., Alziar I., Perret N., Guérin S., Lefkopoulos D., de Vathaire F. Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int J Radiat Oncol Biol Phys. 2009, 74(3):876-883.
5. Schneider U. Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Med Phys 2009, 36(4):1138-1143.
6. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., Mabuchi K., Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007, 168(1):1-64.
7. Schneider U., Walsh L. Cancer risk above 1 Gy and the impact for space radiation protection. Adv Space Res 2009, 44(2):202-209.
8. Schneider U., Zwahlen D., Ross D., Kaser-Hotz B. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005, 61(5):1510-1515.
9. Zubal I.G., Harrell C.R., Smith E.O., Rattner Z., Gindi G., Hoffer P.B. Computerized three-dimensional segmented human anatomy. Med Phys 1994, 21(2):299-302.
10. Gupta R.K., Gospodarowicz M.K., Lister T.A. Clinical evaluation and staging of Hodgkin's disease. Hodgkin's disease. 1999, 223-240. Lippincott Williams & Wilkins, Philadelphia. 1st ed. P. Mauch, J. Armitage, V. Diehl (Eds.).
11. Mauch P.M., Leslie A.K., Kadin M., et al. Patterns of presentation of Hodgkin Disease. Cancer 1993, 71(6):2062-2071.
12. Hoppe R.T. Radiation therapy in the management of Hodgkin's disease. Semin Oncol 1990, 17(6):704-715.
13. Stovall M., Blackwell C.R., Cundiff J., et al. Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys 1995, 22:63-82.
14. Kehwar TS, Sharma SC. Use of normal tissue tolerance doses into linear quadratic equation to estimate normal tissue complication probability. Radiation Oncology Online Journal. http://www.rooj.com/Radiation%20Tissue%20Tolerance.htm.
15. Schneider U., Kaser-Hotz B. A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. Z Med Phys. 2005, 15(1):31-37.
16. Hancock S.L., Hoppe R.T. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Semin Radiat Oncol. 1996, 6(3):225-242.
17. Swerdlow A.J., Barber J.A., Hudson G.V., Cunningham D., Gupta R.K., Hancock B.W., Horwich A., Lister T.A., Linch D.C. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000, 18(3):498-509.
18. Dores G.M., Metayer C., Curtis R.E., Lynch C.F., Clarke E.A., Glimelius B., Storm H., Pukkala E., van Leeuwen F.E., Holowaty E.J., Andersson M., Wiklund T., Joensuu T., van't Veer M.B., Stovall M., Gospodarowicz M., Travis L.B. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002, 20(16):3484-3494.
19. van Leeuwen F.E., Travis L.B. Second cancers. Cancer: Principles & Practice of Oncology 2001, 2939-2964. Lippincott Williams & Wilkins, Philadelphia. 6th ed. V.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.).
20. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A. 2005 13;102(37):13040-5.